Knowledge Center

  • Reset
Cut Timelines and Costs in Late-Phase Oncology: Why Asia Should Be Your Next Trial Destination

15 October 2025

Cut Timelines and Costs in Late-Phase Oncology: Why Asia Should Be Your Next Trial Destination

Globally, cancer diagnoses are projected to reach 35.3 million new cases per year with death rates rising to 18.5 million by 2050.²

Unlocking the Potential of FDA Expedited Approval and Voucher Programs: An Avance Clinical Partnership Approach

15 October 2025

Unlocking the Potential of FDA Expedited Approval and Voucher Programs: An Avance Clinical Partnership Approach

Our integrated approach combines deep regulatory expertise with world-class operational resources to guide Sponsors through every aspect of these complex programs, from initial eligibility assessment to managing post-approval commitments.

Accelerating Development Through Parallel Execution and Rigorous Quality Controls

23 September 2025

Accelerating Development Through Parallel Execution and Rigorous Quality Controls

In a recent video interview with Applied Clinical Trials, Ben Edwards, Chief Operating Officer, Avance Clinical, discussed common challenges in biotech, emphasizing the importance of addressing preclinical package gaps to avoid delays.

Advancing Rare Disease Clinical Trials: A High-Touch, Patient-Centered Approach for Biotechs

17 April 2025

Advancing Rare Disease Clinical Trials: A High-Touch, Patient-Centered Approach for Biotechs

Avance Clinical supports biotech companies by employing patient-centered trial designs, innovative statistical methodologies, personalized patient support, and expert regulatory guidance.

Avance Clinical North America: Proven Expertise With Global Solutions For US Biotechs

6 March 2025

Avance Clinical North America: Proven Expertise With Global Solutions For US Biotechs

The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

Ensure Seamless Clinical Trial Transition Across Global Markets

17 January 2025

Ensure Seamless Clinical Trial Transition Across Global Markets

To enable access to life-saving therapeutics, drug sponsors continue to explore new strategies for executing their clinical trials as rapidly and efficiently as possible.

Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research

5 January 2025

Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research

The rapidly evolving landscape of oncology clinical trials, driven by innovative technologies and deeper insights into cancer biology, presents unique challenges and opportunities for U.S. biotech companies.

Navigating the Risks: Why Compassionate Use Should Not Replace Rigorous Clinical Trials

20 December 2024

Navigating the Risks: Why Compassionate Use Should Not Replace Rigorous Clinical Trials

Recently, we have observed an increasing number of queries from clients exploring the potential of utilizing 'special access-like schemes' to obtain clinical data, as an alternative to conducting properly structured clinical trials, due to challenges in securing necessary funding.

Accessing Unapproved Therapeutic Modalities in the USA and Australia

4 December 2024

Accessing Unapproved Therapeutic Modalities in the USA and Australia

Both the United States and Australia have established regulatory frameworks to address these needs, governed by the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), respectively.

Demystifying Cell and Gene Therapy Studies in Australia and the Broader APAC Region

19 November 2024

Demystifying Cell and Gene Therapy Studies in Australia and the Broader APAC Region

The global cell and gene therapy (CGT) industry continues to accelerate, thanks to its potential to generate life-changing treatments across a range of chronic indications, including cancers and rare diseases.

How Avance Clinical’s In-house ClinicReady Service Supports Early-Stage Biotech Companies to Secure Funding

10 October 2024

How Avance Clinical’s In-house ClinicReady Service Supports Early-Stage Biotech Companies to Secure Funding

For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development. Avance Clinical, a leading contract research organization (CRO), offers tailored consultancy services to help biotech companies navigate the investment process to bring their innovations to market.

The Asia Advantage: Why US Biotechs Should Look East for Clinical Trials

2 September 2024

The Asia Advantage: Why US Biotechs Should Look East for Clinical Trials

This article explores the compelling reasons behind the Asia Advantage and highlights how Avance Clinical's strategic expansion into the region supports biotechs in maximizing these benefits.

Proven industry
experience & expertise

800+

Studies in the past 10 years

500+

Experienced team members

33k+

Participants past 10 years

30

Years of CRO experience